Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IBRX
#815
ImmunityBio, Inc. Common Stock
9.7
8
+3.93%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+3.93%
Monthly Change
+63.00%
6 month change
+312.66%
Cambio anual
+213.46%
Cierres anteriores
9.4
1
Open
9.7
8
Bid
Ask
Low
9.7
8
High
9.7
8
Volumen
189
Markets
Acciones
Atención Sanitaria
IBRX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
109.34 M
397.91 M
435.84 M
673.95 M
853.44 M
1.03 B
—
Valuation ratios
Enterprise value
—
2.24 B
1.98 B
3.27 B
2.04 B
1.95 B
9.27 B
Price to earnings ratio
—
-6.83
-4.59
-4.56
-4.13
-5.21
-22.26
Price to sales ratio
—
2 533.77
7 948.02
4 284.97
121.61
16.08
155.25
Price to cash flow ratio
—
-8.62
-5.65
-7.27
-4.58
-5.97
-24.09
Price to book ratio
—
9.77
4.26
4.54
3.67
3.64
6.31
Enterprise value to EBITDA ratio
—
—
—
—
-6.25
25.23
-301.82
Profitability ratios
Return on assets %
0.61
0.74
1.15
1.16
1.08
0.7
0.91
Return on equity %
0.79
1.42
0.93
1
0.85
0.7
0.63
Return on invested capital %
406.3
499.16
255.34
327.6
630.3
482.51
477.01
Gross margin %
100
100
100
100
100
99.34
397.58
Operating margin %
82.55 K
35.36 K
146.37 K
58.24 K
2 334.23
226
1 002.3
EBITDA margin %
—
—
—
—
-2 215.18
68.17
308.16
Net margin %
83.23 K
37.13 K
173.57 K
93.76 K
2 804.77
310.18
1 506.74
Liquidity ratios
Quick ratio
—
—
—
—
3.21
5.08
16.76
Current ratio
3.06
0.91
0.28
5.05
3.36
5.1
17.19
Inventory turnover
—
—
—
—
0
0.16
0.15
Asset turnover
0
0
0
0
0.03
0.26
0.27
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
-0.18
1.66
0.74
0.65
2.99
Long term debt to total equity ratio
—
—
-0.14
1.43
0.58
0.65
2.29
Per share metrics
Operating cash flow per share
—
0.7
0.84
0.72
0.56
0.33
0.34
EBIT per share
—
—
—
—
-0.49
0.07
0.08
EBITDA per share
—
—
—
—
-0.47
0.08
0.1
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
0.81
0.27
0.52
0.21
0.26
0.78
Net current asset value per share
—
0.86
0.35
0.58
0.26
0.34
1.05
Tangible book value per share
—
0.62
1.07
1.12
0.68
0.53
2.37
Working capital per share
—
-0.09
-0.9
0.46
0.19
0.28
0.81
Book value per share
—
0.62
1.12
1.15
0.7
0.54
2.43
Noticias
Simon, director, vende acciones de ImmunityBio (IBRX) por 900.000 dólares
Director Simon vende acciones de ImmunityBio (IBRX) por $900k
Simon, director, sells ImmunityBio (IBRX) shares worth $900k
ImmunityBio completa inscripción en ensayo de cáncer de vejiga
ImmunityBio completes enrollment in bladder cancer trial
ImmunityBio Investors Rally Behind Cancer Trial Milestone - ImmunityBio (NASDAQ:IBRX)
Netflix and Palantir among market cap stock movers on Wednesday
ImmunityBio Supersedes Expectations With Fivefold Revenue Increase - ImmunityBio (NASDAQ:IBRX)
Directora de Immunitybio vende acciones por $250,000
Barry J. Simon vende acciones de ImmunityBio (IBRX) por $1.78 millones
AMD and Keysight Technologies among market cap stock movers on Tuesday
Tesla, Oracle among market cap stock movers on Monday